Objective
To demonstrate the medical, technical and economic viability of a protective glove used by health staff (surgeons, doctors, dentists,.nurses..) against the risk of transmission of infectious diseases (AIDS, Herpes, Hepatitis, bacteria...) during medical acts (injections, blood tests, insertion and removal catheters,...).
Objectives:
Setting to work a pilot system to demonstrate the medical, technical and economic viability of a protective glove used by health staff(surgeons, doctors, dentists, nurses) against the risk of transmission of infectious diseases (AIDS, Herpes, Hepatitis, bacteria) during medical acts (injections, blood tests, insertion and removing catheters).
Innovative dimension.
The concept of a biocide glove involves new technology for a new application. The European Award awarded it for Innovation in 1995.The new technology: the biocide glove consists of three superposed elastomer layers: two external hypoallergenic layers (internal and external) and an intermediate layer composed of a biocide emulsion. In case of percutaneous accidents ("prick" and perforation of the glove) the blood inside and outside the needle is instantaneously sterilised. The new application: no biocide glove exists on the market at the present moment. The worldwide classical medical glove market (text latex gloves and surgical gloves) produces about 50 billions gloves per year. So the world-wide market for biocide gloves can be of about yearly 2 billions ECU.
Work content:
The project will include 6 main tasks as follows: Task 1: Construction of the pilot system; Task 2: Production of biocide emulsion; Task 3: Manufacturing of gloves; Task 4: Testing of biocide efficiency; Task 5: Monitoring; Task 6: Management of the project.
The minimum pilot capacity will be at least 1000 pairs of gloves per day to verify, on a scale of operations representing reality, the different aspects which might affect the implementation of the new technology. Some of the gloves produced will be used for perfecting manufacturing procedure. The remainder will be distributed to some Public Health Organisations and Medical User Glove Organisation in order to evaluate the acceptance degree of the new technology.
Expected results: A glove reducing by a factor more than 100 the risk of contamination of health staff- Manufacturing process with no defects- Manufacturing cost on an industrial scale comparable to the classical medical gloves. By the execution of this demonstration project it would be possible, with minimal risk, to build the first production line for biocide medical gloves in the European Community.
Fields of science
- engineering and technologymechanical engineeringmanufacturing engineering
- medical and health scienceshealth sciencespublic health
- natural sciencesbiological sciencesmicrobiologybacteriology
- medical and health scienceshealth sciencesinfectious diseasesRNA virusesHIV
- engineering and technologymedical engineeringmedical laboratory technologylaboratory samples analysis
Topic(s)
Call for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
75008 Paris
France